Prepair 500+
Gene: CTSA
Lysosomal storage disease associated with a combined deficiency of beta-galactosidase and neuraminidase, secondary to a defect in protective protein/cathepsin A. All patients have coarse facies, cherry red spots, vertebral changes, foam cells in the bone marrow, and vacuolated lymphocytes. 3 clinical forms described: early infantile form is associated with fetal hydrops, oedema, ascites, visceromegaly, skeletal dysplasia, and early death. The late infantile type is characterized by hepatosplenomegaly, growth restriction, cardiac involvement, and rare occurrence of neurologic signs. The juvenile/adult form is characterized by myoclonus, ataxia, angiokeratoma, intellectual impairment, neurologic deterioration, absence of visceromegaly. The majority of reported patients belong to the juvenile/adult group and are mainly of Japanese origin
Overall, variable age of onset, including severe early infantile presentations.
Reported causal variants include missense, nonsense, frameshift, and splice-altering variants.
Multiple animal models and functional studies present.Created: 24 Oct 2024, 11:10 p.m. | Last Modified: 24 Oct 2024, 11:10 p.m.
Panel Version: 1.486
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Galactosialidosis MIM#256540
Publications
Gene: ctsa has been classified as Green List (High Evidence).
Phenotypes for gene: CTSA were changed from Galactosialidosis, 256540 (3) to Galactosialidosis MIM#256540
Publications for gene: CTSA were set to
gene: CTSA was added gene: CTSA was added to Prepair 500+. Sources: Mackenzie's Mission,Expert Review Green Mode of inheritance for gene: CTSA was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: CTSA were set to Galactosialidosis, 256540 (3)